Acyclic nucleoside analogues with carboxamido-or nitro-substituted heterocyclic bases have been evaluated for their possible use as universal bases in oligodeoxynucleotides. The acyclic moiety endows the constructs with enough flexibility to allow good base stacking. The 5-nitroindazole analogue afforded the most stable duplexes among the acyclic derivatives with the least spread in 7" m versus the four natural bases. In spite of the acyclic moiety, stabilities are comparable with those of duplexes incorporating the recently described 5-nitroindole nucleoside analogue, but considerably exceed those for the 3-nitropyrrole analogue.
INTRODUCTION
Efforts to isolate the gene coding for a newly identified protein are often based on the use of synthetic hybridisation probes based on a partially known amino acid sequence. However, the redundancy of the genetic code mostly leads to a multitude of possible DNA sequences. Therefore, many research efforts have been undertaken trying to devise a truly ambiguous base or 'lure' nucleoside analogue, capable of base-pairing equally well with all four natural bases. In the past 2'-deoxyinosine (dl) has been advocated as the solution for such degenerate positions (1), but dl pairs much more strongly to dC compared with the other bases, and therefore cannot be considered as the perfect ambiguous or 'universal' base.
More recently, 1 -(2'-deoxy-pVD-ribofuranosyl)-3-nitropyrrole (2) was proposed as a valuable universal nucleoside (2) and is commercialized for these purposes. However, Loakes already reported the inefficiency of this nucleoside in fulfilling these criteria, and highly reduced T m values were noted, when incorporating this analogue once or at several positions (3) . An alternative analogue which did look very promising however, was the 5-nitroindole derivative (3) which even upon multiple incorporation into an oligonucleotide hybridized quite well with its complement (reduction in T m of 22°C for incorporation of six analogues into a 17mer) (3) .
Another approach which could be followed is to combine base modifications with sugar alterations of the nucleoside. Because of the conformational flexibility of acyclic nucleosides, one could expect that the base-pairing properties of such analogues could be different from the traditional Watson-Crick base-pairing. This flexibility could allow the base of the analogue to position itself and allow perfect base-pairing with all four natural base moieties. Our previous findings already indicated the acyclic hypoxanthine analogue 1 to be a good candidate as a universal base: only a small spread in T m versus the complementary sequences was noticed when incorporated at a degenerate position (4) . However, the slight destabilisation of the duplex (a drop in T m of 5 °C compared with incorporation of the normal Watson-Crick base pairs) led us to look for a base analogue which would yield analogous ambiguous pairing with all four natural bases as the counterpart, but without a drop in melting temperature. This would allow for multiple incorporation of the acyclic analogue in probes as well as in primers without the need for lowering the annealing temperature too much to allow the oligonucleotide analogue to pair with its target A preliminary account of these results was given recently (5) .
Five new acyclic nucleoside analogues with unnatural base moieties were prepared. These include 5-amino-4-imidazole-carboxamide (6), 4,5-imidazoledicarboxamide (10), 3,5-pyrazoledicarboxamide (13), 4-nitroimidazole (15) and 5-nitroindazole (17) . Because of synthetic considerations, these compounds have a 4(/?)-methoxy-3(S),5-dihydroxypentyl side chain instead of the 3(5),5-dihydroxypentyl group as in the already described 1. The stereochemistry of both chiral centers is established by the choice of the starting material. The compounds 10, 15 and 17 were converted to their dimethoxytritylated phosphoramidites and were successfully incorporated into oligonucleotides after which the hybridizing properties of these oligonucleotides were evaluated. These results are compared with those of the reference compounds 1-3. The incorporation of 6 and 13 was impeded by troublesome synthesis of the respective phosphoramidites.
RESULTS
l-C>-Methanesulfonyl-3,5-di-0-benzyl-4-0-methyl-2-deoxy-Dribitol (4) (6) was subjected to nucleophilic substitution with the different bases. Coupling with 4-amino-5-imidazolecarboxamide was accomplished by prior deprotonation with NaH in DMF, after which the mixture was heated at 50°C to yield 75% of the protected analogue 5. Debenzylation by transfer hydrogenation with cyclohexene (6) afforded 70% of 6 as an oil. Following 5'-Odimethoxytritylation (50% yield), phosphitylation of 21 was found to take place primarily at the base moiety yielding mono-and diphosphitylated analogues. The monophosphitylated species only contained base modified material and 26 was not detected. Protection of the base moiety thus seems mandatory to incorporate this AICAR analogue in an oligonucleotide using regular phosphoramidite chemistry. Previously, the 2'-deoxy analogue of AICAR was rather unexpectedly incorporated into oligonucleotides in moderate yield, using a protected derivative of 2-aza-2'-deoxyinosine (7) . However, all protecting strategies we tried (benzoyl, p-nitrophenylethyloxycarbonyl, dimethylformamidine) failed, in the sense that the protecting groups chosen could not be introduced properly, and incorporation of this analogue was not pursued any further. Others likewise have had difficulties in trying to incorporate the deoxyribosyl analogue of AICAR into oligonucleotides (8) .
Analogous coupling of dicyanoimidazole with 4 required a temperature of 90°C to yield 45% of the protected analogue 7. Conversion to the bisamide 9 was accomplished with hydrogen peroxide under phase-transfer catalysed conditions in 31 % yield (9), followed by transfer hydrogenation to yield 75% of 10. This route was preferred over the alternative one which first debenzylates 7-8 in 73% with the aid of boron trichloride (10) leaving the nitrile moieties untouched and then converts the intermediate to the bisamide 10 with aqueous hydrogen peroxide.
Pyrazole-3,5-dicarboxylic acid was converted to the diethyl ester with ethylchloroformate in 90% yield. Coupling to 4 in the presence of potassium carbonate for 16 h at 60°C afforded 73% of the protected analogue 11. Treatment with anhydrous ammonia in ethanol for 48 h at 100°C in a pressurized bottle, followed by debenzylation afforded 32% of 13. While the 4,5-dicarboxamidoimidazole derivative 10 was converted to its phosphoramidite derivative 23 and incorporated into oligonucleotides without noticable difficulties, the pyrazole analogue, like the amino-imidazolecarboxamide, could not be functionalized to 27 to allow incorporation into oligomers. Again the base was phosphitylated in preference to the hydroxyl moiety.
4-Nitroimidazole and 5-nitroindazole were condensed with 4 in a moderate 37 and 32% yield, respectively, of the N'-glycosylated products, with the aid of NaH. Deduction of the site of attachment of the acyclic moiety was based on NMR and UV data of analogous compounds (refs 11-12 and 13, respectively). Debenzylation to 15 and 17 was accomplished with boron trichloride 1 M in methylene chloride at -78°C (75% yield) leaving the nitro substituent untouched (10) .
The analogues 10,15 and 17 were 5'-0-dimethoxytritylated and phosphitylated following standard procedures and the obtained phosphoramidites were used for incorporation of these analogues into oligonucleotides, but a 0.13 M solution was used as compared with the usual 0.1 M solution of phosphoramidites. This gave good coupling efficiency as reflected by the HPLC ion exchange profile (not shown). The target sequence was a 13mer with the modification positioned in the middle. Melting temperatures with the four complementary sequences were determined (Table 1) .
Whereas the acyclic inosine analogue 1 gave a spread of 4.8 C C, the 5-nitroindazole 17 and the 4,5-imidazoledicarboxamide 10 gave only 2.2 and 3.7°C, respectively. This narrow range in 7" m for oligonucleotides containing 17, warrants this analogue to be pursued further as a universal nucleoside at ambiguous sites in DNA primers (data not cited). Melting temperatures, however, are lower when compared with those containing a natural Watson-Crick base pair, but acceptable when compared with those incorporating 2'-deoxyinosine. Compared with the recently reported analogue 2 containing a 3-nitropyrrole substituent (2), our acyclic analogue 17 and the nitroindole nucleoside 3 behave much more effective. The analogue 2 is reported to be a universal nucleoside, and oligonucleotides containing 2 at several sites were reported to be useful as primers for sequencing and for PCR, while melting temperatures of these oligonucleotides in comparison with their control sequences were not given. For the sequences studied here, however, incorporation of 2 is detrimental to duplex stability. Destabilisation is of the same order as for incorporation of 1,2-dideoxy-l-phenyl-P-D-ribofuranose or the abasic counterpart 1,2-dideoxy-D-ribofuranose (14) , and duplexes are less stable than those containing an A-C mismatch for the sequence reported here (4). Table 2 . Again, 3 and 17 are clearly superior to the nitropyrrole analogue 2, but melting temperatures drop markedly with the third incorporation of an analogue in this test sequence, which is in contrast with the up to six incorporations reported for the nitroindole analogue 3 without noticing unsurmountable destabilization (3).
Analogously to Habener et al. (15) and Loakes and Brown (3), some thermodynamic calculations were carried out using the 'all or none' two state model developed by Gralla and Crothers (16) . Hereto, absorbance values were sampled at a rate of 2 points/min with an increase in temperature of 0.2°C/min. The derivative at each point on the curve was determined by fitting a regression line to the point in a dynamically specified window containing 40 points (4°C). The transition enthalpy can be calculated from the equation as discussed in these references. The duplexes with a single mismatch versus T were included in this study for comparison purposes. For the nitropyrrole, the third mismatch destroys almost completely the duplex, but a second smaller transition (better visible on the curve for the derivative) was visible at 54°C. However, the free energy at 37 °C for the duplexes with a single or double mismatch, clearly show the unfavorable effect of incorporation of 2. While the enthalpy after three incorporations of the acyclic 17 drops tremendously, this is compensated by the lower loss in entropy compared with 3, which makes incorporation of 17 still advantagous compared with 3 for this test sequence. The stability of all new analogues has been verified in two other test sequences, used before by Kawase etal.(ll) when evaluating deoxyinosine as a universal base. Table 3 uses a test sequence with the analogue in the middle of an A-T stretch, which might give a different tertiary structure (and different results) as compared with a random mixed sequence. All analogues cause about the same destabilisation, with the acyclic deoxyinosine 1 as second best after deoxyinosine itself, but with less spreading in T m compared with the latter. Analyzing the third test sequence (Table 4) containing two mismatches in the middle next to each other, the nitroindole 3 emerges as the best hybridizing analogue with the least spread of 7ms, slightly better than the acyclic nitroindazole 17. Both analogues are clearly superior to dl with respect for this sequence, where, unexpectedly, the duplex is strongly destabilized with a double dl-dG mismatch. 
CONCLUSION
Five new acyclic nucleoside analogues were prepared for incorporation into oligomers, of which two could not be incorporated due to phosphitylation of the heterocyclic base, prior to reaction of the secondary alcohol. 7ms of the different analogues versus all four natural bases were determined for three different test sequences known from the literature, and spread of the 7 m values was compared with that for other 'universal' nucleoside analogues 1-3 and dl. We can conclude that selection of the best analogue is somewhat dependent on the sequence and that the recently described 5-nitroindole nucleoside analogue 3, and especially the new acyclic nitroindazole analogue 17, are valuable candidates for use as universal nucleoside analogues. While 7 m s in general still are somewhat lower as compared with the natural complementary bases, spread in 7 m s are much smaller, which is one of the prime criterion for a universal analogue. The use of these analogues in hybridisation probes and in PCR experiments, is the subject for further work.
MATERIALS AND METHODS
All general methods including synthesis and purification of oligonucleotides and determination of melting temperatures were as recently described (18) .
An amount of 1.34 g (8.25 mmol) of 4-amino-5-imidazolecarboxamide was treated with 725 mg (18.1 mmol) of a 60% oil dispersion of NaH for 30 min at room temperature in 50 ml DMF, after which the suspension was gently heated to 50°C. The methanesulfonyl derivative 4 (2.27 g of an oil, 5.5 mmol) was added as a 10 ml DMF solution and the mixture was left overnight at 50°C. The reaction was quenched with water, evaporated and adsorbed on silica gel. Gradient elution (CH 2 Cl 2 -Me0H 0-5%) afforded 1.81 g (4.12 mmol, 75%) of the title product as an oil. An amount of 1.84 g (4.27 mmol) of 7 was dissolved in 3 ml CH 2 Cl2 and cooled on an ice bath. Sequentially, 4 ml of a 30% H^ solution, 440 mg (1.3 mmol) of tetrabutylammonium hydrogen sulfate and 3.2 ml of a 20% NaOH solution were added. The biphasic mixture was stirred for 1 h at room temperature, after which the mixture was partitioned between CH 2 C1 2 and saturated NaCl. Column purification on silica gel afforded 636 mg (1.37 mmol, 32%) as a foam.
" 
l-(4-0-methyl-2-deoxy-D-ribityl)-4,5-dicarboxamidoimidaz£>le 10.
A: the dicyanoimidazole derivative 8 (78 mg, 0.312 mmol) was dissolved in 1 ml cone. NH4OH and 0.5 ml of a 30% H2O2 solution was added. The mixture was stirred for 20 h at room temperature, concentrated, and coevaporated twice with dioxane. Purification on a preparative silica gel plate (CH2Cl2-MeOH 85:15) afforded 42 mg (0.15 mmol, 48%) of the title product 10.
B: an amount of 1.14 g (2.44 mmol) of the benzylated derivative 9 was deprotected by transfer hydrogenation as described for the preparation of 7. After filtration, the residue was adsorbed on silica gel, and column purification (CH2Cl2-MeOH 9:1) afforded 510 mg (1.78 mmol, 75%) of 10 as a white solid.
UV ( Diethyl 3,5-pyrazpledicarboxylale. 3,5-Pyrazoledicarboxylic acid monohydrate (3.5 g, 20 mmol) was dissolved in 100 ml anhydrous pyridine, 7.7 ml (80 mmol) ethylchloroformate was added and the mixture was stirred for 48 h. Concentration afforded an oil which was partitioned between CH2CI2 and aqueous NaHCO3. Purification on silica gel (CH 2 C1 2 to CH 2 Cl 2 -MeOH 99:1) afforded 3.83 g (18.1 mmol, 90%) of the title product as a yellow oil. 13 . Debenzylation of the acyclic analogue 12 (1.80 g, 3.86 mmol) was accomplished by transfer hydrogenation as described for the preparation of 7. After filtration, the residue was adsorbed on silica gel, and column purification (CH 2 
l-(3,5-Di-0-benzyl-4-0-methyl-2-deoxy-D-ribityl)-diethyl-3,5-py

-(4-O-methyl-2-deoxy-D-ribityl)-3,5-pyrazoledicarboxamide
l-(3,5-Di-O-benzyl-4-O-methyl-2-deoxy-D-ribityl)-4-nitroimidazole 14.
4-Nitroimidazole (1.7 g, 15 mmol) was treated with 600 mg (15 mmol) of a 60% oil dispersion of NaH in 50 ml of DMF for 1 h at 60°C, after which 4.1 g (10 mmol) of the methanesulfonate 4 dissolved in 20 ml DMF was added. The mixture was heated at 60 °C for 24 h, concentrated and partitioned between CH 2 C1 2 and aqueous NaHCO3-Column purification (CH 2 C1 2 to CH 2 Cl 2 -MeOH 99:1) afforded 2.12 g (5 mmol, 50%) of the title product as a slightly yellow oil.
UV ( 3Hz, 1H, H5 ).
l-(4-0-methyl-2-deoxy-D-ribityl)-4-nitroimidazole 15.
An amount of 4.25 g (9.9 mmol) of 14 was dissolved in 150 ml CH 2 C1 2 and cooled to -78°C. A pre-cooled 1 M BC1 3 solution in CH 2 C1 2 (45 ml) was added and the mixture was stirred for 1 h at -78°C. After addition of 200 ml of a CH 2 Cl 2 -Me0H mixture (1:1) to quench the reaction, stirring was continued for 30 min at room temperature, the mixture was evaporated, coevaporated with water and adsorbed on silica gel. Purification (CH 2 C1 2 to CH 2 Cl 2 -Me0H 95:5) afforded 1.82 g (7.42 mmol, 75%) of the title product as a slightly yellow oil.
UV ( 
l-(3,5-Di-O-benzyl-4-O-methyl-2-deoxy-D-ribityl)-5-nitroindazole 16
. 5-Nitroindazole (2.45 g, 15 mmol) was treated with 600 mg (15 mmol) of a 60% oil dispersion of NaH in 50 ml DMF for 1 h at 60°C, after which 4.1 g (10 mmol) of the methanesulfonate 4 dissolved in 20 ml DMF was added. The mixture was heated at 60°C for 15 h, concentrated and partitioned between CH2CI2 and aqueous NaHCO3. Double column purification (CH 2 C1 2 to CH 2 Cl 2 -Me0H 99:1) afforded 1.52 g (3.2 mmol, 32%) of the title product as a slightly yellow oil.
UV ( l- (5-0-dirnethaxytrityl-4-0-methyl-2-deoxy-[)-ribityl) 
The above dimethoxytritylated derivative 18 (353 mg, 0.6 mmol) was dissoved in 5 ml dichloromethane under argon and diisopropylethylamine (0.32 ml, 1.8 mmol) and 2-cyanoethyl A^-diisopropylchlorophosphoramidite (0.2 ml, 0.9 mmol) were added and the solution was stirred for 1 h. Ethanol (2 ml) was added and the solution stirred for 10 min and then partitioned between CH2CI2 (50 ml) and aqueous NaHCCb (50 ml). The organic phase was washed with aqueous sodium chloride (2x 30 ml) and evaporation of the organics left an oil which was flash chromato- 
Attempted synthesis of 1 -[3-0-(P-$-Cyanoethyl-N,N-diisopropylaminophosphinyl)-5-0-dimethoxytrityl-4-0-methyl-2-deoxy-Dribityl]-3,5-pyrazoledicarboxamide 27.
The dimethoxytritylated derivative 22 (1.26 g, 2.15 mmol) was phosphitylated as before. Two major products were detected by TLC (Rf 0.26 and 0.40 in hexane:EtOAc:TEA, 49:49:2) and both products were partially separated following flash chromatography using the same system as the eluting solvent. NMR and MS analysis indicated both products to be phosphitylated on the base moiety as for the attempted synthesis of 26.
Less polar one: 13 
